View Amendment Current Amendment: 1a to Bill 3819 Reps. FRY and HENDERSON propose the following Amendment No. 1a to H. 3819 (COUNCIL\VR\3819C005.CC.VR18):

Reference is to Printer's Date 3/29/18-H.

Amend the bill, as and if amended, SECTION 1, by striking Section 44-53-363(C) and (D) and inserting:

/            (C)(1)      The requirements set forth in subsection (A) do not apply if the minor's treatment with an opioid analgesic:
           (a)      is associated with or incident to a medical emergency;
           (b)      is associated with or incident to surgery, regardless of whether the surgery is performed on an inpatient or outpatient basis;
           (c)      is associated with pain management treatment for palliative care, cancer care, or hematological disorders including, but not limited to, sickle cell disease;
           (d)      is associated with the treatment of neonatal abstinence syndrome;
           (e)      is limited to liquid antitussive medication;
           (f)      in the prescriber's professional judgment, fulfilling the requirements of subsection (A) would be a detriment to the minor's health or safety;
           (g)      except as provided in subsection (D), the treatment is rendered in a hospital, emergency facility, ambulatory surgical facility, nursing home, pediatric respite care program, residential care facility, freestanding rehabilitation facility, or similar institutional facility;
           (h)      is ordered by a practitioner issuing a prescription for a Schedule II controlled substance to treat a hospice-certified patient;
           (i)            is ordered by a practitioner issuing a prescription for a Schedule II controlled substance that does not exceed a five-day supply for a patient; or
           (j)            is ordered by a practitioner prescribing a Schedule II controlled substance for a patient with whom the practitioner has an established relationship for the treatment of a chronic condition; however, the practitioner must review the patient's controlled substance history maintained in the prescription drug monitoring program at least every three months.
           (2)      The requirements of subsection (A) do not apply to a prescription for an opioid analgesic that a prescriber issues to a minor at the time of discharge from a facility or other location described in subsection (C)(1)(g).
     (D)      The exemption provided pursuant to subsection (C)(1)(g) does not apply to treatment rendered in a prescriber's office that is located on the premises of or adjacent to a facility or other location described in that subsection.            /

Amend the bill further, as and if amended, by striking SECTION 2 and inserting:

/            SECTION      2.       This act takes effect six months after approval by the Governor.            /

Renumber sections to conform.
Amend title to conform.